Search alternatives:
marked decrease » marked increase (Expand Search)
doses decrease » costs decreased (Expand Search), sizes decrease (Expand Search), scores decreased (Expand Search)
three doses » three cases (Expand Search), three phases (Expand Search)
marked decrease » marked increase (Expand Search)
doses decrease » costs decreased (Expand Search), sizes decrease (Expand Search), scores decreased (Expand Search)
three doses » three cases (Expand Search), three phases (Expand Search)
-
1
(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis.
Published 2025Subjects: -
2
Dose and time dependent decrease in the viability of cancer cells upon treatment with vitamin D3.
Published 2025“…A dose dependent increase in cytotoxic effect was observed with increasing vitamin D3 concentration. …”
-
3
Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia.
Published 2025“…For the late high dose treatment, the decrease in Aβ plaque count was also colocalized with decreased microglia.…”
-
4
-
5
-
6
-
7
-
8
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque count.
Published 2025“…(B) Long-term-treatment with a low dose of netoglitazone also exhibits a patchy effect in decreasing plaque count. …”
-
9
Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size.
Published 2025“…(D) Long-term treatment with a high dose of netoglitazone displays a decrease in plaque size, particularly observed in the orbital cortex, olfactory area, hippocampus, thalamus, hypothalamus, midbrain, and hindbrain regions.…”
-
10
-
11
Table 3_The impact of decreased prognostic nutritional index on the prognosis of patients with pneumonia treated with glucocorticoids: a multicenter retrospective cohort study.docx
Published 2025“…Multivariable Cox regression showed that, after full adjustment for potential confounders, every 2-unit decrease in PNI was associated with a 10% higher 30-day mortality hazard (HR = 1.10, 95% CI = 1.05–1.15, p < 0.001) and a 9% higher 90-day mortality hazard (HR = 1.09, 95% CI = 1.04–1.14, p < 0.001). …”
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model.
Published 2025Subjects: -
19
-
20